Who
Vishwas Seshadri
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Abeona Therapeutics.
In numbers
- Trades disclosed
- 43
- Buys
- 3
- Sells
- 13
- Bought
- $201K
- Sold
- $4.0M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Jun 2021
- Last trade
- 29 Sep 2026
- Last filed
- 29 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Sep 2026filed 29 Sep 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $101K19,608 at $5.16 | filing |
| 29 Sep 2026filed 29 Sep 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $101K19,608 at $5.16 | filing |
| 9 Jul 2026filed 9 Jul 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $473K67,971 at $6.96 | filing |
| 9 Jul 2026filed 9 Jul 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $473K67,971 at $6.96 | filing |
| 9 Jun 2026filed 9 Jun 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $169K31,916 at $5.30 | filing |
| 9 Jun 2026filed 9 Jun 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $169K31,916 at $5.30 | filing |
| 8 Jun 2026filed 9 Jun 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $133K24,428 at $5.43 | filing |
| 8 Jun 2026filed 9 Jun 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $133K24,428 at $5.43 | filing |
| 31 Mar 2026filed 31 Mar 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $131K29,985 at $4.38 | filing |
| 31 Mar 2026filed 31 Mar 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $131K29,985 at $4.38 | filing |
| 22 Jan 2026filed 22 Jan 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $372K69,832 at $5.33 | filing |
| 22 Jan 2026filed 22 Jan 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $372K69,832 at $5.33 | filing |
| 20 Jan 2026filed 20 Jan 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —365,422 at $0.00 | filing |
| 20 Jan 2026filed 20 Jan 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —365,422 at $0.00 | filing |
| 29 Dec 2025filed 29 Dec 2025 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $133K25,000 at $5.31 | filing |
| 16 Oct 2025filed 16 Oct 2025 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,367249 at $5.49 | filing |
| 30 Sep 2025filed 1 Oct 2025 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $131K25,000 at $5.24 | filing |
| 29 Sep 2025filed 1 Oct 2025 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $104K19,274 at $5.39 | filing |
| 9 Jul 2025filed 10 Jul 2025 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $407K69,420 at $5.86 | filing |
| 6 Jun 2025filed 6 Jun 2025 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $343K50,676 at $6.76 | filing |
News
No headline names them, or the companies they trade most, lately.